Literature DB >> 17321903

Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations.

Derek Middleton1, Asensio Gonzalez, Paula M Gilmore.   

Abstract

A KIR2DS4 deletion variant allele, previously identified through killer immunoglobulinlike receptor (KIR) polymerase chain reaction-sequence-specific oligonucleotide probe (PCR-SSOP) typing, was functionally investigated using an in vitro cell line model system and in vivo protein expression studies. The KIR2DS4 deletion variant has previously been found in 80% of individuals from Northern Ireland, indicating that it is present at a high incidence in this population. It differs from the normal KIR2DS4 sequence by a 22 bp deletion in exon 5, which causes a frame shift, yielding a truncated KIR2DS4 protein with loss of the transmembrane and cytoplasmic domains of the full-length KIR2DS4 protein. This study has determined that the deleted variant of KIR2DS4 is not anchored to the cell membrane but encodes a soluble form of the protein that is potentially secreted. The frequencies of the deleted and nondeleted versions were also determined in several world-wide populations. A trend was observed towards decreased frequencies of KIR2DS4 deleted variant occurrence in populations having KIR2DS4 as the only activating KIR gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17321903     DOI: 10.1016/j.humimm.2006.12.007

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  41 in total

1.  Differential RNA expression of KIR alleles.

Authors:  Colum McErlean; Asensio A Gonzalez; Rodat Cunningham; Ashley Meenagh; Tanya Shovlin; Derek Middleton
Journal:  Immunogenetics       Date:  2010-05-08       Impact factor: 2.846

Review 2.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

3.  A natural killer cell receptor takes sharp aim at the world of bacteria.

Authors:  Peter Parham
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-07       Impact factor: 11.205

Review 4.  Conserved and variable natural killer cell receptors: diverse approaches to viral infections.

Authors:  Leidy Y Bastidas-Legarda; Salim I Khakoo
Journal:  Immunology       Date:  2019-01-17       Impact factor: 7.397

5.  The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia.

Authors:  Adam J de Smith; Kyle M Walsh; Martha B Ladner; Siming Zhang; Carmen Xiao; Franziska Cohen; Theodore B Moore; Anand P Chokkalingam; Catherine Metayer; Patricia A Buffler; Elizabeth A Trachtenberg; Joseph L Wiemels
Journal:  Blood       Date:  2014-02-11       Impact factor: 22.113

6.  Investigation of deletion of 22pb in KIR2DS4 gene in a population of southern Brazil.

Authors:  Amanda Vansan Marangon; Jeane Eliete Laguila Visentainer; Gláucia Andréia Soares Guelsin; Samaia Laface Clementino; Cristiane Conceição Chagas Rudnick; Fabiano Cavalcante de Melo; Marco Antonio Braga; Ana Maria Sell
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

Review 7.  The extensive polymorphism of KIR genes.

Authors:  Derek Middleton; Faviel Gonzelez
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

8.  Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand.

Authors:  Jill A Hollenbach; Martha B Ladner; Koy Saeteurn; Kent D Taylor; Ling Mei; Talin Haritunians; Dermot P B McGovern; Henry A Erlich; Jerome I Rotter; Elizabeth A Trachtenberg
Journal:  Immunogenetics       Date:  2009-09-30       Impact factor: 2.846

9.  Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5.

Authors:  Noriko K Steiner; Sivanesan Dakshanamurthy; Christopher J VandenBussche; Carolyn K Hurley
Journal:  Immunogenetics       Date:  2008-08-06       Impact factor: 2.846

10.  KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.

Authors:  Thorsten Graef; Achim K Moesta; Paul J Norman; Laurent Abi-Rached; Luca Vago; Anastazia M Older Aguilar; Michael Gleimer; John A Hammond; Lisbeth A Guethlein; David A Bushnell; Philip J Robinson; Peter Parham
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.